133 related articles for article (PubMed ID: 38116599)
1. Comparison of Laboratory and Non-Laboratory-Based 2019 World Health Organization Cardiovascular Risk Charts in the Bhutanese Population.
Chhezom K; Gurung MS; Wangdi K
Asia Pac J Public Health; 2024 Jan; 36(1):29-35. PubMed ID: 38116599
[TBL] [Abstract][Full Text] [Related]
2. Comparison of laboratory-based and non-laboratory-based WHO cardiovascular disease risk charts: a population-based study.
Rezaei F; Seif M; Gandomkar A; Fattahi MR; Malekzadeh F; Sepanlou SG; Hasanzadeh J
J Transl Med; 2022 Mar; 20(1):133. PubMed ID: 35296342
[TBL] [Abstract][Full Text] [Related]
3. Performance of the non-laboratory based 2019 WHO cardiovascular disease risk prediction chart in Eastern Sub-Saharan Africa.
Bendera A; Nakamura K; Seino K; Alemi S
Nutr Metab Cardiovasc Dis; 2024 Jun; 34(6):1448-1455. PubMed ID: 38499452
[TBL] [Abstract][Full Text] [Related]
4. WHO Non-Lab-Based CVD Risk Assessment: A Reliable Measure in a North Indian Population.
Ananda Selva Das P; Dubey M; Kaur R; Salve HR; Varghese C; Nongkynrih B
Glob Heart; 2022; 17(1):64. PubMed ID: 36199565
[TBL] [Abstract][Full Text] [Related]
5. Ten-years cardiovascular risk among Bangladeshi population using non-laboratory-based risk chart of the World Health Organization: Findings from a nationally representative survey.
Hanif AAM; Hasan M; Khan MSA; Hossain MM; Shamim AA; Hossaine M; Ullah MA; Sarker SK; Rahman SMM; Bulbul MMI; Mitra DK; Mridha MK
PLoS One; 2021; 16(5):e0251967. PubMed ID: 34038457
[TBL] [Abstract][Full Text] [Related]
6. Agreement between the laboratory-based and non-laboratory-based WHO cardiovascular risk charts: a cross-sectional analysis of a national health survey in Peru.
Guzman-Vilca WC; Quispe-Villegas GA; Váscones Román FF; Bernabe-Ortiz A; Carrillo-Larco RM
BMJ Open; 2022 Nov; 12(11):e063289. PubMed ID: 36344007
[TBL] [Abstract][Full Text] [Related]
7. Laboratory-based and office-based risk scores and charts to predict 10-year risk of cardiovascular disease in 182 countries: a pooled analysis of prospective cohorts and health surveys.
Ueda P; Woodward M; Lu Y; Hajifathalian K; Al-Wotayan R; Aguilar-Salinas CA; Ahmadvand A; Azizi F; Bentham J; Cifkova R; Di Cesare M; Eriksen L; Farzadfar F; Ferguson TS; Ikeda N; Khalili D; Khang YH; Lanska V; León-Muñoz L; Magliano DJ; Margozzini P; Msyamboza KP; Mutungi G; Oh K; Oum S; Rodríguez-Artalejo F; Rojas-Martinez R; Valdivia G; Wilks R; Shaw JE; Stevens GA; Tolstrup JS; Zhou B; Salomon JA; Ezzati M; Danaei G
Lancet Diabetes Endocrinol; 2017 Mar; 5(3):196-213. PubMed ID: 28126460
[TBL] [Abstract][Full Text] [Related]
8. Laboratory-based versus non-laboratory-based World Health Organization risk equations for assessment of cardiovascular disease risk.
Dehghan A; Rayatinejad A; Khezri R; Aune D; Rezaei F
BMC Med Res Methodol; 2023 Jun; 23(1):141. PubMed ID: 37322418
[TBL] [Abstract][Full Text] [Related]
9. Performance of WHO updated cardiovascular disease risk prediction charts in a low-resource setting - Findings from a community-based survey in Puducherry, India.
Sivanantham P; Kar SS; Lakshminarayanan S; Sahoo JP; Bobby Z; Varghese C
Nutr Metab Cardiovasc Dis; 2022 Sep; 32(9):2129-2136. PubMed ID: 35752538
[TBL] [Abstract][Full Text] [Related]
10. Place of cardiovascular risk prediction models in South Asians; agreement between Framingham risk score and WHO/ISH risk charts.
Mettananda KCD; Gunasekara N; Thampoe R; Madurangi S; Pathmeswaran A
Int J Clin Pract; 2021 Jul; 75(7):e14190. PubMed ID: 33780102
[TBL] [Abstract][Full Text] [Related]
11. Estimation of the cardiovascular risk using World Health Organization/International Society of Hypertension (WHO/ISH) risk prediction charts in a rural population of South India.
Ghorpade AG; Shrivastava SR; Kar SS; Sarkar S; Majgi SM; Roy G
Int J Health Policy Manag; 2015 Apr; 4(8):531-6. PubMed ID: 26340393
[TBL] [Abstract][Full Text] [Related]
12. A comparative assessment between Globorisk and WHO cardiovascular disease risk scores: a population-based study.
Dehghan A; Rezaei F; Aune D
Sci Rep; 2023 Aug; 13(1):14229. PubMed ID: 37648706
[TBL] [Abstract][Full Text] [Related]
13. Agreement Between Cardiovascular Disease Risk Scores in Resource-Limited Settings: Evidence from 5 Peruvian Sites.
Bazo-Alvarez JC; Quispe R; Peralta F; Poterico JA; Valle GA; Burroughs M; Pillay T; Gilman RH; Checkley W; Malaga G; Smeeth L; Bernabé-Ortiz A; Miranda JJ;
Crit Pathw Cardiol; 2015 Jun; 14(2):74-80. PubMed ID: 26102017
[TBL] [Abstract][Full Text] [Related]
14. Laboratory-based and office-based Globorisk scores to predict 10-year risk of cardiovascular diseases among Iranians: results from the Fasa PERSIAN cohort.
Jahangiry L; Dehghan A; Farjam M; Aune D; Rezaei F
BMC Med Res Methodol; 2022 Nov; 22(1):305. PubMed ID: 36435774
[TBL] [Abstract][Full Text] [Related]
15. Concordance between two versions of world health organization/international society of hypertension risk prediction chart and framingham risk score among postmenopausal women in a rural area of Bangladesh.
Barua L; Faruque M; Banik PC; Ali L
Indian J Public Health; 2019; 63(2):101-106. PubMed ID: 31219057
[TBL] [Abstract][Full Text] [Related]
16. Comparative assessment of absolute cardiovascular disease risk characterization from non-laboratory-based risk assessment in South African populations.
Gaziano TA; Pandya A; Steyn K; Levitt N; Mollentze W; Joubert G; Walsh CM; Motala AA; Kruger A; Schutte AE; Naidoo DP; Prakaschandra DR; Laubscher R
BMC Med; 2013 Jul; 11():170. PubMed ID: 23880010
[TBL] [Abstract][Full Text] [Related]
17. Assessment of total cardiovascular risk using WHO/ISH risk prediction charts in three low and middle income countries in Asia.
Otgontuya D; Oum S; Buckley BS; Bonita R
BMC Public Health; 2013 Jun; 13():539. PubMed ID: 23734670
[TBL] [Abstract][Full Text] [Related]
18. Agreement between laboratory-based and non-laboratory-based Framingham risk score in Southern Iran.
Rezaei F; Seif M; Gandomkar A; Fattahi MR; Hasanzadeh J
Sci Rep; 2021 May; 11(1):10767. PubMed ID: 34031448
[TBL] [Abstract][Full Text] [Related]
19. Application of two versions of the WHO/international society of hypertension absolute cardiovascular risk assessment tools in a rural Bangladeshi population.
Fatema K; Zwar NA; Milton AH; Rahman B; Ali L
BMJ Open; 2015 Oct; 5(10):e008140. PubMed ID: 26463220
[TBL] [Abstract][Full Text] [Related]
20. Estimation of total cardiovascular risk using the 2019 WHO CVD prediction charts and comparison of population-level costs based on alternative drug therapy guidelines: a population-based study of adults in Bangladesh.
Islam JY; Zaman MM; Moniruzzaman M; Ara Shakoor S; Hossain AHME
BMJ Open; 2020 Jul; 10(7):e035842. PubMed ID: 32690512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
